Zheng Cui, PhD
- Associate Professor Emeritus, Pathology (Winston-Salem)

Zheng Cui, PhD
- Positions
- Associate Professor Emeritus, Pathology (Winston-Salem)
- Departments and Affiliations
- Pathology (Winston-Salem)
Research
- Granulocytes as an effector mechanism of BCG therapy for bladder cancer. Davis RL, Le W, Cui Z. Med. Hypotheses. 2017 Jul; 104:166-169.
- Novel innate cancer killing activity in humans. Blanks MJ, Stehle JR, Du W, Adams JM, Willingham MC, Allen GO, Hu JJ, Lovato J, Molnar I, Cui Z. . 2011 Aug; 11:26.
- The spectrum of resistance in SR/CR mice: the critical role of chemoattraction in the cancer/leukocyte interaction. Riedlinger G, Adams J, Stehle JR, Blanks MJ, Sanders AM, Hicks AM, Willingham MC, Cui Z. BMC Cancer. 2010 May; 10:179.
- Cancer resistance of SR/CR mice in the genetic knockout backgrounds of leukocyte effector mechanisms: determinations for functional requirements. Sanders AM, Stehle JR, Blanks MJ, Riedlinger G, Kim-Shapiro JW, Monjazeb AM, Adams JM, Willingham MC, Cui Z. BMC Cancer. 2010 Mar; 10:121.
- Impact of sex, MHC, and age of recipients on the therapeutic effect of transferred leukocytes from cancer-resistant SR/CR mice. Stehle JR, Blanks MJ, Riedlinger G, Kim-Shapiro JW, Sanders AM, Adams JM, Willingham MC, Cui Z. BMC Cancer. 2009 Sep; 9:328.